X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs VENUS REMEDIES - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS VENUS REMEDIES J.B.CHEMICALS/
VENUS REMEDIES
 
P/E (TTM) x 14.2 -819.1 - View Chart
P/BV x 2.2 0.2 934.1% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   VENUS REMEDIES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
VENUS REMEDIES
Mar-16
J.B.CHEMICALS/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs318218 145.9%   
Low Rs20082 243.0%   
Sales per share (Unadj.) Rs148.0365.6 40.5%  
Earnings per share (Unadj.) Rs19.11.5 1,284.2%  
Cash flow per share (Unadj.) Rs23.937.9 63.1%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.9382.5 33.7%  
Shares outstanding (eoy) m84.8211.44 741.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.4 426.2%   
Avg P/E ratio x13.6101.0 13.4%  
P/CF ratio (eoy) x10.84.0 273.1%  
Price / Book Value ratio x2.00.4 511.7%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9511,717 1,278.8%   
No. of employees `0002.71.0 268.0%   
Total wages/salary Rs m1,841324 567.6%   
Avg. sales/employee Rs Th4,590.94,100.7 112.0%   
Avg. wages/employee Rs Th673.4318.0 211.7%   
Avg. net profit/employee Rs Th592.116.7 3,552.4%   
INCOME DATA
Net Sales Rs m12,5514,183 300.1%  
Other income Rs m54220 2,694.5%   
Total revenues Rs m13,0934,203 311.5%   
Gross profit Rs m2,055812 253.2%  
Depreciation Rs m412417 98.9%   
Interest Rs m96380 25.2%   
Profit before tax Rs m2,08835 5,949.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46918 2,591.7%   
Profit after tax Rs m1,61917 9,521.8%  
Gross profit margin %16.419.4 84.4%  
Effective tax rate %22.551.6 43.6%   
Net profit margin %12.90.4 3,173.1%  
BALANCE SHEET DATA
Current assets Rs m7,7782,771 280.7%   
Current liabilities Rs m4,3581,931 225.6%   
Net working cap to sales %27.220.1 135.8%  
Current ratio x1.81.4 124.4%  
Inventory Days Days55125 43.7%  
Debtors Days Days8054 148.9%  
Net fixed assets Rs m5,7135,328 107.2%   
Share capital Rs m170114 148.3%   
"Free" reserves Rs m10,5474,177 252.5%   
Net worth Rs m10,9374,376 249.9%   
Long term debt Rs m01,911 0.0%   
Total assets Rs m15,5748,428 184.8%  
Interest coverage x22.81.1 2,089.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.5 162.4%   
Return on assets %11.04.7 233.8%  
Return on equity %14.80.4 3,809.9%  
Return on capital %20.06.6 302.5%  
Exports to sales %48.70-   
Imports to sales %7.120.5 34.5%   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889858 103.5%   
Fx inflow Rs m6,1690-   
Fx outflow Rs m1,285858 149.7%   
Net fx Rs m4,884-858 -569.0%   
CASH FLOW
From Operations Rs m1,397469 297.9%  
From Investments Rs m-32029 -1,096.9%  
From Financial Activity Rs m-1,196-464 258.0%  
Net Cashflow Rs m-10235 -296.5%  

Share Holding

Indian Promoters % 55.4 32.9 168.6%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.2 1,883.3%  
FIIs % 3.9 0.6 672.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 66.4 55.7%  
Shareholders   30,437 20,121 151.3%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   TORRENT PHARMA  ALKEM LABORATORIES  IPCA LABS  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 18, 2017 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS